Search
for

    Research 10 of 1000+

    1. Implementing patient safety and quality improvement in dermatology. Part 1: Patient safety science Journal of the American Academy of Dermatology · 2022 · 1 citations
    2. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Zenodo (CERN European Organization for Nuclear Research) · 2026
    3. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Zenodo (CERN European Organization for Nuclear Research) · 2026
    4. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Zenodo (CERN European Organization for Nuclear Research) · 2026
    5. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Open Science Framework · 2026
    6. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Zenodo (CERN European Organization for Nuclear Research) · 2026
    7. Uncontrolled Clinical Trial of Quality- and Quantity-cultured Peripheral Blood Mononuclear Cell Treatment for Androgenic Alopecia Plastic & Reconstructive Surgery · 2025
    8. Biomimetic Scaffolds—A Novel Approach to Three Dimensional Cell Culture Techniques for Potential Implementation in Tissue Engineering Nanomaterials · 2024 · 1 citations
    9. Complications and Limitations of Melanocyte Transplantation 2018
    10. Surgical Therapies Springer eBooks · 2019
    All research results →

    Learn 5 of 33

    1. KY19382 Experimental compound that activates hair-growth signals, tested only in animals
    2. Exosomes Tiny cell-derived particles offered by clinics as an injectable treatment
    3. Rosemary Herb whose oil is used in hair care
    4. Hair Multiplication extract, clone, and reinsert your own hair cells
    5. Valproic acid Anti-seizure and mood-stabilising drug
    All learn results →

    Community 10 of 282

    1. PP405 2a study was a safety study. Some rational explaining. Reddit · 1 Sept 2025
    2. Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA Reddit · 19 Jul 2023
    3. Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study Reddit · 20 Aug 2026
    4. Kintor long term safety phase 3 Reddit · 21 Mar 2025
    5. Effectiveness and Safety of Hair Growth Formulation Containing Tectona grandis L.f (Teak) Leaf Extract Reddit · 3 Nov 2024
    6. KX-826: Long-Term Safety Results are out! Reddit · 16 Oct 2024
    7. 2.5mg dut safety/price/synergy w/topical fin Reddit · 28 Feb 2024
    8. How can I safely apply RU58841 whilst I have children in the house? Reddit · 3 Jan 2026
    9. How to safely stop topical finasteride? Community · 11 May 2025
    10. Study: You can safely conceive on Dutasteride Reddit · 21 Apr 2025
    All community results →